COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $312,802 | -62.1% | 83,637 | -56.8% | 0.00% | – |
Q2 2023 | $825,875 | -23.1% | 193,413 | +23.2% | 0.00% | – |
Q1 2023 | $1,073,443 | -14.2% | 156,936 | -0.7% | 0.00% | – |
Q4 2022 | $1,250,816 | -16.1% | 158,031 | +1.9% | 0.00% | -100.0% |
Q3 2022 | $1,491,000 | +34.9% | 155,052 | +1.6% | 0.00% | – |
Q2 2022 | $1,105,000 | -44.1% | 152,609 | -0.3% | 0.00% | -100.0% |
Q1 2022 | $1,976,000 | -20.0% | 153,086 | -1.1% | 0.00% | 0.0% |
Q4 2021 | $2,471,000 | +2.6% | 154,788 | +3.3% | 0.00% | 0.0% |
Q3 2021 | $2,409,000 | +21.9% | 149,864 | +4.9% | 0.00% | 0.0% |
Q2 2021 | $1,977,000 | -25.8% | 142,922 | -21.6% | 0.00% | 0.0% |
Q1 2021 | $2,664,000 | -13.0% | 182,336 | +3.5% | 0.00% | 0.0% |
Q4 2020 | $3,063,000 | -4.8% | 176,200 | +0.5% | 0.00% | 0.0% |
Q3 2020 | $3,217,000 | +5.8% | 175,404 | +3.0% | 0.00% | 0.0% |
Q2 2020 | $3,041,000 | +1216.5% | 170,292 | +1096.5% | 0.00% | – |
Q1 2020 | $231,000 | -14.8% | 14,233 | -5.5% | 0.00% | – |
Q4 2019 | $271,000 | -4.6% | 15,064 | +7.3% | 0.00% | – |
Q3 2019 | $284,000 | +10.5% | 14,042 | +20.6% | 0.00% | – |
Q2 2019 | $257,000 | +96.2% | 11,642 | +21.4% | 0.00% | – |
Q1 2019 | $131,000 | +59.8% | 9,592 | +5.5% | 0.00% | – |
Q4 2018 | $82,000 | -38.3% | 9,095 | +12.3% | 0.00% | – |
Q3 2018 | $133,000 | +30.4% | 8,097 | +11.0% | 0.00% | – |
Q2 2018 | $102,000 | +30.8% | 7,294 | +2.3% | 0.00% | – |
Q1 2018 | $78,000 | -15.2% | 7,128 | -31.4% | 0.00% | – |
Q4 2017 | $92,000 | -33.8% | 10,387 | 0.0% | 0.00% | – |
Q3 2017 | $139,000 | +3.7% | 10,387 | +11.2% | 0.00% | – |
Q2 2017 | $134,000 | -22.5% | 9,341 | +12.6% | 0.00% | – |
Q1 2017 | $173,000 | -14.4% | 8,295 | +15.9% | 0.00% | – |
Q4 2016 | $202,000 | +83.6% | 7,158 | +74.0% | 0.00% | – |
Q3 2016 | $110,000 | +66.7% | 4,114 | 0.0% | 0.00% | – |
Q2 2016 | $66,000 | -19.5% | 4,114 | 0.0% | 0.00% | – |
Q1 2016 | $82,000 | -18.8% | 4,114 | -6.7% | 0.00% | – |
Q4 2015 | $101,000 | +11.0% | 4,411 | 0.0% | 0.00% | – |
Q3 2015 | $91,000 | -26.0% | 4,411 | 0.0% | 0.00% | – |
Q2 2015 | $123,000 | – | 4,411 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |